Skip to main content

Udit Batra

Merck KGaA announced Udit Batra will lead the combined business resulting from the German firm's $17 billion acquisition of Sigma-Aldrich. The deal is expected to be completed mid-2015. Batra has been CEO and president of Merck since March 2014. He joined the company in 2011 as head of its consumer health business.

The Scan

Response Too Slow, Cautious

A new report criticizes the global response to the threat of the COVID-19 pandemic, Nature News reports.

Pushed a Bit Later

Novavax has pushed back its timeline for filing for authorization for its SARS-CoV-2 vaccine, according to Bloomberg.

AMA Announces Anti-Racism Effort

The Associated Press reports that the American Medical Association has released a plan to address systemic racism in healthcare.

Nucleic Acids Research Papers on miRMaster 2.0, MutationTaster2021, LipidSuite

In Nucleic Acids Research this week: tool to examine small non-coding RNAs, approach to predict ramifications of DNA variants, and more.